4//SEC Filing
Schorno Dean L 4
Accession 0000905148-24-000446
CIK 0001034842other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:18 PM ET
Size
6.5 KB
Accession
0000905148-24-000446
Insider Transaction Report
Form 4
Schorno Dean L
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2024-02-05$1.14/sh−7,027$8,011→ 402,891 total - Sale
Common Stock
2024-02-02$1.13/sh−5,601$6,327→ 409,918 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $1.1228 to $1.13. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission staff, full information regarding the shares sold at each such separate price.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001509688
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:18 PM ET
- Size
- 6.5 KB